The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Abstract
FBW7 (F-box and WD repeat domain-containing 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase. SCF(FBW7) degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN. FBW7 is also a tumour suppressor, the regulatory network of which is perturbed in many human malignancies. Numerous cancer-associated mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis. This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FBXW7 ubiquitin ligase is a component of the SCF complex and mediates degradation of several cell cycle proteins,158 and its β-isoform is induced by p53.159”
From Census and evaluation of p53 target genes (2017) · cites this paper as [158]
Citations
Cites
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Many mitogens induce JUN activity, and JUN functions as part of the AP1 transcription factor to exert its positive effect on cell proliferatio”
BackgroundActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Genetic Control of the Cell Division Cycle in Yeast
Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,450
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M. G., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,421
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 1,000
Zhang, P., Sheng, L., Wang, G., Tian, M., Zhu, L., Zhang, R., Zhang, J., & Zhu, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9169 · Cited by 64
Cullin Ring Ubiquitin Ligases (CRLs) in Cancer: Responses to Ionizing Radiation (IR) Treatment
Fouad, S., Wells, O. S., Hill, M. A., & D’Angiolella, V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01144 · Cited by 67
FBXW7 is involved in the acquisition of the malignant phenotype in epithelial ovarian tumors
Kitade, S., Onoyama, I., Kobayashi, H., Yagi, H., Yoshida, S., Kato, M., Tsunematsu, R., Asanoma, K., Sonoda, K., Wake, N., et al. (2016) · Cancer Science · doi:10.1111/cas.13026 · Cited by 62
PRMT5-mediated arginine methylation stabilizes GPX4 to suppress ferroptosis in cancer
Fan, Y., Wang, Y., Dan, W., Zhang, Y., Nie, L., Ma, Z., Zhuang, Y., Liu, B., Li, M., Liu, T., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01610-3 · Cited by 62
GSK3-SCFFBXW7 targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase
Pérez‐Benavente, B., Garcı́a, J. L., Rodríguez, M. S., Pineda‐Lucena, A., Piechaczyk, M., de Mora, J. F., & Farrás, R. (2012) · Oncogene · doi:10.1038/onc.2012.235 · Cited by 62
Kitagawa, K., Hiramatsu, Y., Uchida, C., Isobe, T., Hattori, T., Oda, T., SHIBATA, K., Nakamura, S., Kikuchi, A., & Kitagawa, M. (2009) · Oncogene · doi:10.1038/onc.2009.111 · Cited by 62
Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins
Zheng, N., Wang, Z. P., & Wei, W. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.02.005 · Cited by 64
Writing and erasing MYC ubiquitination and SUMOylation
Chen, Y., Sun, X., Sears, R. C., & Dai, M. (2019) · Genes & Diseases · doi:10.1016/j.gendis.2019.05.006 · Cited by 64
Yumimoto, K., Yamauchi, Y., & Nakayama, K. I. (2020) · Cancers · doi:10.3390/cancers12051249 · Cited by 65
Cellular senescence and protein degradation
Deschênes‐Simard, X., Lessard, F., Gaumont‐Leclerc, M., Bardeesy, N. M., & Ferbeyre, G. (2014) · Cell Cycle · doi:10.4161/cc.29335 · Cited by 66
Current views on the role of Notch signaling and the pathogenesis of human leukemia
Pancewicz, J., & Nicot, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-502 · Cited by 60
Knobel, P. A., Belotserkovskaya, R., Galanty, Y., Schmidt, C. K., Jackson, S. P., & Stracker, T. H. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00197-14 · Cited by 60
Rossi, D., Ciardullo, C., & Gaïdano, G. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.04.002 · Cited by 62
miR‑27a promotes human breast cancer cell migration by inducing EMT in a FBXW7‑dependent manner
Jiang, G., Shi, W., Fang, H., & Zhang, X. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9587 · Cited by 59
Non-Coding microRNAs as Novel Potential Tumor Markers in Testicular Cancer
Regouc, M., Belge, G., Lorch, A., Dieckmann, K., & Pichler, M. (2020) · Cancers · doi:10.3390/cancers12030749 · Cited by 58
Orphan quality control shapes network dynamics and gene expression
Mark, K. G., Kolla, S., Aguirre, J. D., Garshott, D. M., Schmitt, S., Haakonsen, D. L., Xu, C., Kater, L., Kempf, G., Martínez-González, B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.06.015 · Cited by 61
Chiang, C.-P., Chu, P., Hou, M., & Hung, W. (2016) · Europe PMC (PubMed Central) · Cited by 58
Roy, S., Pradhan, D., Ernst, W. L., Mercurio, S., Najjar, Y. G., Parikh, R. A., Parwani, A. V., Pai, R. K., Dhir, R., & Nikiforova, M. N. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.33 · Cited by 58
Tu, K., Zheng, X. M., Zhou, Z., Li, C., Zhang, J., Gao, J., Yao, Y., & Liu, Q. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068574 · Cited by 58
RetractedFAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance
Bartel, C. A., Parameswaran, N., Cipriano, R., & Jackson, M. W. (2016) · Oncotarget · doi:10.18632/oncotarget.9544 · Cited by 57
Fhu, C. W., & Ali, A. (2021) · Cancers · doi:10.3390/cancers13071513 · Cited by 59
Two diphosphorylated degrons control c-Myc degradation by the Fbw7 tumor suppressor
Welcker, M., Wang, B., Rusnac, D.-V., Hussaini, Y., Swanger, J., Zheng, N., & Clurman, B. E. (2022) · Science Advances · doi:10.1126/sciadv.abl7872 · Cited by 57
Self-citationPellegrino, N., Güven, A., Gray, K., Shah, P., Kasture, G., Nastke, M.-D., Thakurta, A., Gesta, S., Vishnudas, V. K., Narain, N. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073480 · Cited by 58
Degrons: defining the rules of protein degradation
Zhang, Z., Mena, E. L., Timms, R. T., Koren, I., & Elledge, S. J. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00870-z · Cited by 67
Tang, X., Orlicky, S. M., Mittag, T., Csizmók, V., Pawson, T. J., Forman-Kay, J. D., Sicheri, F., & Tyers, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116455109 · Cited by 61
Role of SKP1-CUL1-F-Box-Protein (SCF) E3 Ubiquitin Ligases in Skin Cancer
Xie, C., Wei, W., & Sun, Y. (2013) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2013.02.001 · Cited by 61
Fbxw7 regulates Notch to control specification of neural precursors for oligodendrocyte fate
Snyder, J. L., Kearns, C. A., & Appel, B. (2012) · Neural Development · doi:10.1186/1749-8104-7-15 · Cited by 57
Zhang, Y., Zhang, X., Ye, M., Jing, P., Xiong, J., Han, Z., Kong, J., Li, M., Lai, X., Chang, N., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.047 · Cited by 57
Loss of USP28-mediated BRAF degradation drives resistance to RAF cancer therapies
Saei, A., Palafox, M., Benoukraf, T., Kumari, N., Jaynes, P. W., Iyengar, P. V., Muñoz‐Couselo, E., Nuciforo, P. G., Cortés, J., Nötzel, C., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171960 · Cited by 58
Mutation profiling of cancer drivers in Brazilian colorectal cancer
dos Santos, W., Sobanski, T., de Carvalho, A. C., Evangelista, A. F., Matsushita, M., Berardinelli, G. N., de Oliveira, M. A., Reis, R. M., & Guimarães, D. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-49611-1 · Cited by 57
mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why?
Sun, S. (2020) · Frontiers of Medicine · doi:10.1007/s11684-020-0812-7 · Cited by 58
Phan, V. T., Ding, V. W., Li, F., Chalkley, R. J., Burlingame, A. L., & McCormick, F. P. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01450-08 · Cited by 58
Zhu, J., Li, Y., Chen, C., Ma, J., Sun, W., Tian, Z., Li, J., Xu, J., Liu, C. S., Zhang, D., et al. (2017) · Neoplasia · doi:10.1016/j.neo.2017.06.002 · Cited by 56
Qiao, X., Liu, Y., Prada, M. L., Mohan, A. K., Gupta, A., Jaiswal, A., Sharma, M., Merisaari, J., Haikala, H. M., Talvinen, K., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1647 · Cited by 56
Hundley, F. V., Sanvisens, N., Marin, H. C., Carr, K. L., Tian, R., & Toczyski, D. P. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.01.014 · Cited by 56
Involvement of F-BOX proteins in progression and development of human malignancies
Shahab Uddin, M. S., Bhat, A. A., Krishnankutty, R., Mir, F. A., Kuliński, M., & Mohammad, R. M. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.008 · Cited by 57
Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late
Remmerie, M., & Janssens, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082380 · Cited by 56
Morra, F., Luise, C., Merolla, F., Poser, I., Visconti, R., Ilardi, G., Paladino, S., Inuzuka, H., Guggino, G., Monaco, R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3708 · Cited by 54
Ubiquitin-dependent Proteasomal Degradation of Human Liver Cytochrome P450 2E1
Wang, Y., Guan, S., Acharya, P., Koop, D. R., Liu, Y., Liao, M., Burlingame, A. L., & Correia, M. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.176685 · Cited by 56
RNF34 Is a Cold-Regulated E3 Ubiquitin Ligase for PGC-1 α and Modulates Brown Fat Cell Metabolism
Wei, P. Y., Pan, D., Mao, C., & Wang, Y. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05674-11 · Cited by 53
Tu, K., Zheng, X. M., ZAN, X., Han, S., Yao, Y., & Liu, Q. (2012) · Hepatology Research · doi:10.1111/j.1872-034x.2012.01005.x · Cited by 53
Protein-mediated viral latency is a novel mechanism for Merkel cell polyomavirus persistence
Kwun, H. J., Chang, Y., & Moore, P. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703879114 · Cited by 53
Koo, J., Yue, P., Deng, X., Khuri, F. R., & Sun, S. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01525-14 · Cited by 53
Mitosis as an anti-cancer drug target
Salmela, A.-L., & Kallio, M. J. (2013) · Chromosoma · doi:10.1007/s00412-013-0419-8 · Cited by 53
miR-194 targets RBX1 gene to modulate proliferation and migration of gastric cancer cells
Chen, X., Wang, Y., Zang, W., Du, Y., Li, M., & Zhao, G. (2014) · Tumor Biology · doi:10.1007/s13277-014-2849-1 · Cited by 52
Yumimoto, K., Matsumoto, M., Onoyama, I., Imaizumi, K., & Nakayama, K. I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.465179 · Cited by 52
Liu, Y., Tong, Z., Li, T., Chen, Q., Zhuo, L., Li, W., Wu, R., & Yu, C. (2012) · Hepatology · doi:10.1002/hep.25751 · Cited by 52
Liu, Y., Koyutürk, M., Barnholtz‐Sloan, J. S., & Chance, M. R. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-65 · Cited by 52
Golgi-associated RhoBTB3 targets Cyclin E for ubiquitylation and promotes cell cycle progression
Lu, A., & Pfeffer, S. R. (2013) · The Journal of Cell Biology · doi:10.1083/jcb.201305158 · Cited by 53
Structural Biology of CRL Ubiquitin Ligases
Rusnac, D.-V., & Zheng, N. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_2 · Cited by 53
Favero, A., Segatto, I., Perin, T., & Belletti, B. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1659 · Cited by 52
Wang, F. F., Zhang, X. J., Yan, Y., Zhu, X., Yu, J., Ding, Y., Hu, J., Zhou, W., Zeng, Z., Liao, W., et al. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.11.031 · Cited by 51
RING-finger E3 ligases regulatory network in PI3K/AKT-mediated glucose metabolism
Wang, W., Shi, B., Cong, R., Hao, M., Peng, Y., Yang, H., Song, J., Feng, D., Zhang, N., & Li, D. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01162-7 · Cited by 51
Rictor regulates FBXW7-dependent c-Myc and cyclin E degradation in colorectal cancer cells
Guo, Z., Zhou, Y., Evers, B. M., & Wang, Q. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.01.054 · Cited by 51
Kossatz-Boehlert, U., Breuhahn, K., Wolf, B., Hardtke‐Wolenski, M., Wilkens, L., Steinemann, D., Singer, S., Brass, F., Kubicka, S., Schlegelberger, B., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41959 · Cited by 51
Early stage uterine serous carcinoma: Management updates and genomic advances
Fader, A. N., Santin, A. D., & Gehrig, P. A. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.01.004 · Cited by 51
Xiao, Y., Su, C., & Deng, T. (2016) · Oncology Letters · doi:10.3892/ol.2016.5115 · Cited by 51
MiR-182 promotes cell proliferation by suppressing FBXW7 and FBXW11 in non-small cell lung cancer.
Chang, H., Liu, Y., Wang, L., Wang, J., Zhao, Z., Qu, J., & Sheng-fa, W. (2018) · Europe PMC (PubMed Central) · Cited by 51
Askew, E. B., Bai, S., Hnat, A. T., Minges, J. T., & Wilson, E. M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.065979 · Cited by 52
Converging mechanism of UM171 and KBTBD4 neomorphic cancer mutations
Xie, X., Zhang, O., Yeo, M. J. R., Lee, C., Tao, R., Harry, S. A., Payne, N. C., Nam, E., Paul, L., Li, Y., et al. (2025) · Nature · doi:10.1038/s41586-024-08533-3 · Cited by 50
Zhang, B., Liu, Q., Wen, W., Gao, H., Wei, W., Tang, A., Qin, B., Lyu, H., Meng, X., Li, K., et al. (2022) · Cell Discovery · doi:10.1038/s41421-022-00478-z · Cited by 52
Notch-dependent cell cycle arrest and apoptosis in mouse embryonic fibroblasts lacking Fbxw7
Ishikawa, Y., Onoyama, I., Nakayama, K., & Nakayama, K. (2008) · Oncogene · doi:10.1038/onc.2008.216 · Cited by 50
FBXW7 is involved in Aurora B degradation
Teng, C. J., Hsieh, Y.-C., Phan, L. M., Shin, J., Gully, C., Velázquez-Torres, G., Skerl, S., Yeung, S. J., Hsu, S., & Lee, M. (2012) · Cell Cycle · doi:10.4161/cc.22381 · Cited by 50
Ding, J., Zhao, Z., Song, J. T., Luo, B., & Huang, L. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy040 · Cited by 50
Prevention of cancer dormancy by Fbxw7 ablation eradicates disseminated tumor cells
Shimizu, H., Takeishi, S., Nakatsumi, H., & Nakayama, K. I. (2019) · JCI Insight · doi:10.1172/jci.insight.125138 · Cited by 53
Iriuchishima, H., Takubo, K., Matsuoka, S., Onoyama, I., Nakayama, K. I., Nojima, Y., & Suda, T. (2010) · Blood · doi:10.1182/blood-2010-07-294801 · Cited by 53
MYC is a critical target of FBXW7
Sato, M., Barrueco, R. R., Yu, J., Do, C., Silva, J. M., & Gautier, J. (2014) · Oncotarget · doi:10.18632/oncotarget.3203 · Cited by 49
Iżykowska, K., Przybylski, G. K., Gand, C., Braun, F., Grabarczyk, P., Kuss, A. W., Olek‐Hrab, K., Torres, A. N. B., Vermeer, M. H., Zoutman, W. H., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17383 · Cited by 49
Koo, J., Yue, P., Gal, A. A., Khuri, F. R., & Sun, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2946 · Cited by 49
Merkel Cell Polyomavirus: Molecular Insights into the Most Recently Discovered Human Tumour Virus
Stakaitytė, G., Wood, J. J., Knight, L., Abdul-Sada, H., Adzahar, N., Nwogu, N., Macdonald, A., & Whitehouse, A. (2014) · Cancers · doi:10.3390/cancers6031267 · Cited by 52
Mori, M. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1436 · Cited by 48
Xie, C.-M., Tan, M., Lin, X.-T., Wu, D., Jiang, Y., Tan, Y., Li, H., Ma, Y., Xiong, X., & Sun, Y. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.052 · Cited by 49
von Stechow, L., Typas, D., Puigvert, J. C., Oort, L., Siddappa, R., Pines, A., Vrieling, H., van de Water, B., Mullenders, L. H. F., & Danen, E. H. J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01152-14 · Cited by 48
Protein homeostasis in aging and cancer
Chen, X., Shen, T., Fang, S.-J., Sun, X.-M., Li, G., & Li, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1143532 · Cited by 52
Recognition of BACH1 quaternary structure degrons by two F-box proteins under oxidative stress
Cao, S., Garcia, S. F., Shi, H., James, E. I., Kito, Y., Shi, H., Mao, H., Kaisari, S., Róna, G., Deng, S., et al. (2024) · Cell · doi:10.1016/j.cell.2024.10.012 · Cited by 47
Mori, T., Ikeda, D. D., Yamaguchi, Y., & Unoki, M. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.038 · Cited by 50
Ubiquitination involved enzymes and cancer
Zhou, M., Chen, F., & Chen, H. (2014) · Medical Oncology · doi:10.1007/s12032-014-0093-6 · Cited by 47
Hepatic F-Box Protein FBXW7 Maintains Glucose Homeostasis Through Degradation of Fetuin-A
Zhao, J., Xiong, X., Li, Y., Liu, X., Wang, T., Zhang, H., Jiao, Y., Jiang, J., Zhang, H., Tang, Q., et al. (2018) · Diabetes · doi:10.2337/db17-1348 · Cited by 47
Systematic characterization of pan‐cancer mutation clusters
Buljan, M., Blattmann, P., Aebersold, R. H., & Boutros, M. (2018) · Molecular Systems Biology · doi:10.15252/msb.20177974 · Cited by 47
Deubiquitinating c-Myc: USP36 steps up in the nucleolus
Sun, X., Sears, R. C., & Dai, M. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1093713 · Cited by 48
Zhu, T., Liu, B., Wu, D., Xu, G., & Yang, F. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740884 · Cited by 46
Emerging roles of Cdk8 in cell cycle control
Szilágyi, Z., & Gustafsson, C. M. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.04.010 · Cited by 46
Tumor suppressor Fbxw7 regulates TGFβ signaling by targeting TGIF1 for degradation
Bengoechea-Alonso, M. T., & Ericsson, J. (2010) · Oncogene · doi:10.1038/onc.2010.278 · Cited by 46
Liu, J., Shi, H., Li, X., Chen, G., Larsson, C., & Lui, W. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3807 · Cited by 46
Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond
Khoshbin, A. P., Eskian, M., Keshavarz‐Fathi, M., & Rezaei, N. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0531-9 · Cited by 46
Voutsadakis, I. A. (2012) · Tumor Biology · doi:10.1007/s13277-012-0355-x · Cited by 46
MYC Oncogene: A Druggable Target for Treating Cancers with Natural Products
Chan, K. I., Zhang, S., Li, G., Xu, Y., Cui, L., Wang, Y., Su, H., Tan, W., & Zhong, Z. (2024) · Aging and Disease · doi:10.14336/ad.2023.0520 · Cited by 46
Chen, M. C., Chen, C., Chuang, H.-C., Kulp, S. K., Teng, C.-M., & Chen, C. (2010) · Hepatology · doi:10.1002/hep.23964 · Cited by 45
The two faces of FBW7 in cancer drug resistance
Wang, Z. P., Fukushima, H., Gao, D., Inuzuka, H., Wan, L., Lau, A. W., Liu, P., & Wei, W. (2011) · BioEssays · doi:10.1002/bies.201100101 · Cited by 45
The pseudophosphatase STYX targets the F‐box of FBXW7 and inhibits SCFFBXW7 function
Reiterer, V., Figueras-Puig, C., Guerroué, F. L., Confalonieri, S., Vecchi, M., Jalapothu, D., Kanse, S. M., Deshaies, R. J., Fiore, P. P. D., Behrends, C., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694795 · Cited by 45
Lee, C., An, H., Kim, S. M., Yoo, S.-M., Park, J., Lee, G.-E., Kim, W., Kim, D. J., Kang, H. C., Lee, J. Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909879116 · Cited by 45
Comparative genomic profiling of glandular bladder tumours
for the German study group of bladder cancer, Maurer, A., Ortiz-Bruechle, N., Guricová, K., Rose, M., Morsch, R., Garczyk, S., Stöhr, R., Bertz, S., Golz, R., et al. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02787-8 · Cited by 45
PP2A-B55: substrates and regulators in the control of cellular functions
Amin, P., Awal, S., Vigneron, S., Roque, S., Méchali, F., Labbé, J. C., Lorca, T., & Castro, A. (2021) · Oncogene · doi:10.1038/s41388-021-02068-x · Cited by 45
The Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles' Heel of Cancer Cells?
Ablain, J., Nasr, R., Bazarbachi, A., & de Thé, H. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0087 · Cited by 44
Toward understanding ubiquitin-modifying enzymes: from pharmacological targeting to proteomics
Lill, J. R., & Wertz, I. E. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.01.005 · Cited by 47
Butler, V. J., Salazar, D. A., Soriano‐Castell, D., Alves‐Ferreira, M., Dennissen, F. J. A., Vohra, M., Osés-Prieto, J. A., Li, K. H., Wang, A. L., Jing, B., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy442 · Cited by 44
Ubiquitination and Long Non-coding RNAs Regulate Actin Cytoskeleton Regulators in Cancer Progression
Ma, X., Dang, Y., Shao, X., Chen, X., Wu, F., & Li, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20122997 · Cited by 44
FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation
Richter, K. T., Kschonsak, Y. T., Vodicska, B., & Hoffmann, I. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0385-7 · Cited by 44
Hong, Z., Zhang, W., Ding, D., Huang, Z., Yan, Y., Cao, W., Pan, Y., Hou, X., Weroha, S. J., Karnes, R. J., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.028 · Cited by 44
X‐box binding protein 1 (XBP1) function in diseases
Xu, W., Wang, C., & Hua, J. (2020) · Cell Biology International · doi:10.1002/cbin.11533 · Cited by 44
Metadata
- Authors
- Welcker, M., & Clurman, B. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Welcker, Markus
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 83-93
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2142183096
- Cited by
- 1,084
- References
- 120
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 34 · 2023: 38 · 2022: 53 · 2021: 67 · 2020: 64 · 2019: 69 · 2018: 67 · 2017: 68 · 2016: 74 · 2015: 77 · 2014: 73 · 2013: 82 · 2012: 76
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL084205)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- FBXW7, SCF ubiquitin ligase, tumour suppressor, MYC degradation, cyclin E, notches, c-Jun, chromosomal instability, carcinogenesis, cancer-associated mutations, cell division, cell growth, cell differentiation
- MeSH terms
- F-Box-WD Repeat-Containing Protein 7, Animals, Cell Differentiation, Cell Division, Humans, Models, Biological, Mutation, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Cycle Proteins, Dimerization, Cyclin E, Ubiquitin-Protein Ligases, F-Box Proteins, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review